On April 16, 2020, Wisconsin Secretary-designee of the Department of Health Services, Andrea Palm, issued Emergency Order #28 at the direction of Governor Tony Evers. This new Order extends Wisconsin’s “Safer at Home” Order until 8:00 a.m. on May 26, 2020, or until a superseding order is issued, and modifies the original order. The original Safer at Home Order issued on March 25, Emergency Order #12, remains in effect until April 24, 2020.
BioForward is actively engaged with community partners, elected officials, state agencies and industry partners to meet the challenges of combating the coronavirus and demonstrating that Wisconsin can help lead the nation through this healthcare crisis. PPE Focus Eight Madison-area community providers serving people with developmental disabilities and seniors received much-needed PPE as they battle the […]
Read the full press release from Merck here. Merck (NYSE: MRK), known as MSD outside the United States and Canada, will today announce three significant scientific initiatives to combat COVID-19: two agreements to develop potential vaccines against SARS-CoV-2, and a research collaboration to advance the development of a novel antiviral candidate. Today’s announcements are: Merck […]
Read the full story from genomeweb here.
Read the full press release from PRNewswire here. Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic. The new test is the result of ongoing collaboration between all […]
Read the full story from Healthcare Finance here. The Federal Communications Commission today granted GE Healthcare’s request for a waiver to allow the importation, marketing and operation of certain GE medical devices from new suppliers for use in healthcare facilities. The order, which was issued by the Wireless Telecommunications Bureau and Office of Engineering and […]
Read the full press release from SHINE Medical Technologies here. SHINE Medical Technologies LLC today announced that the U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE by October 2021. SHINE’s application for a license to operate the medical isotope production facility that it […]
Read the full press release from PRNewswire here. Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass. The $180 million project will more than double the company’s commercial […]
Read the full story from the Wisconsin State Journal here. A Madison-based diagnostics company wants to make testing for the COVID-19 coronavirus easier and quicker for patients and health care providers. GoDx has been developing paper-based tests for pathogens that cause gastrointestinal diseases, such as salmonella and norovirus. While those tests are currently undergoing clinical […]
Read the full story from WISCONSININNO. Madison-based Nimble Therapeutics, a fairly new company that was spun out from Switzerland-based F. Hoffmann-La Roche, is collaborating with Roche Diagnostics to discover and develop novel peptide-based molecules for diagnostics of SARS-CoV-2, the virus that causes COVID-19. Nimble Therapeutics is developing a chemical synthesis technology for drug development. The […]
View the full story & video on CNBC here. Dr. Mikael Dolsten, Pfizer chief scientific officer, joins “Squawk Box” to discuss the efforts to develop and test a potential vaccine for Covid-19.